Medical Assistance for the Procreation and Risk of Thrombosis. (AMPERT)

Regional University Hospital Center (CHRU)

Status: Terminated

Conditions: Ovarian Hyperstimulation Syndrome; Embolism and Thrombosis; Cardiovascular Diseases

Treatments: Other: ovarian stimulation

Study type: Observational

Funder types: Other

Identifiers

NCT02610608

AMPERT (RB13.160)

Details and patient eligibility

About

This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation.

Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women

Full description

All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.

Enrollment: 129 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All women undergoing ovarian stimulation in order to receive in vitro fertilization

Exclusion criteria

• Age<18 years
• Women refusing to particpate in the study
• No health coverage
• Women under guardianship
• Women receiving therapeutic doses of anticoagulation

Trial design

129 participants in 1 patient group

Women undergoing ART

Description:

Observation of the incidence of venous and arterial thrombosis following ovarian stimulation

Treatment:

Other: ovarian stimulation